Literature DB >> 4310172

Further observations on the inhibitory effect of myxoviruses on a transplantable murine leukemia.

M D Eaton, A R Scala.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4310172     DOI: 10.3181/00379727-132-34138

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


× No keyword cloud information.
  6 in total

1.  Antiviral immune cytolysis at an early stage of paramyxovirus infection.

Authors:  M D Eaton; A R Scala
Journal:  Infect Immun       Date:  1971-11       Impact factor: 3.441

Review 2.  Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions.

Authors:  Dmitriy Zamarin; Peter Palese
Journal:  Future Microbiol       Date:  2012-03       Impact factor: 3.165

3.  Recent advances of oncolytic virus in cancer therapy.

Authors:  Moumita Mondal; Jingao Guo; Ping He; Dongming Zhou
Journal:  Hum Vaccin Immunother       Date:  2020-02-20       Impact factor: 3.452

4.  Complement-dependent antiviral monospecific antibody-mediated lysis of murine cells coated with Sendai virus or its envelope component.

Authors:  Y Hosaka; Y Fukami; Y Yasuda; J A Bonilla
Journal:  Infect Immun       Date:  1980-02       Impact factor: 3.441

5.  Disease accompanying in utero viral infection. The role of maternal antibody in tissue injury after transplacental infection with lymphocytic choriomeningitis virus.

Authors:  M B Oldstone; F J Dixon
Journal:  J Exp Med       Date:  1972-04-01       Impact factor: 14.307

Review 6.  Trial watch: TLR3 agonists in cancer therapy.

Authors:  Julie Le Naour; Lorenzo Galluzzi; Laurence Zitvogel; Guido Kroemer; Erika Vacchelli
Journal:  Oncoimmunology       Date:  2020-06-02       Impact factor: 8.110

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.